Cholinesterase InhibitorsCholinesterasesAlzheimer DiseasePhenylcarbamatesIndansGalantamineTacrineButyrylcholinesteraseMemantinePhysostigmineAcetylcholinesteraseNootropic AgentsNeostigmineMethomylPiperidinesDiazinonPyridostigmine BromideEdrophoniumTrichlorfonAmyloid beta-PeptidesDementiaParathionOrganothiophosphorus CompoundsBrainChlorpyrifosSarinDisulfotonInsecticidesSomantau ProteinsEchothiophate IodideAmyloid beta-Protein PrecursorCognition DisordersParaoxonNeurofibrillary TanglesAcetylcholineNeuropsychological TestsDementia, VascularAldicarbLewy Body DiseaseCarbamatesPlaque, AmyloidMental Status ScheduleMuscarinic AntagonistsChemical Warfare AgentsParasympathomimeticsApolipoprotein E4Cholinesterase ReactivatorsOrganophosphorus CompoundsReality TherapyThiocholinePseudocholinesteraseCholineNeurotoxicity SyndromesAminacrineAtropineCognitionAmyloid Precursor Protein SecretasesDibucaineDose-Response Relationship, DrugDopamine AgentsPresenilin-1Receptors, MuscarinicMuscarinic AgonistsAmyloidTetraisopropylpyrophosphamideAtrophyCholinergic AntagonistsDichlorvosOrganophosphate PoisoningNeurofibrilsBradycardiaCerebral CortexMild Cognitive ImpairmentCholinergic AgentsPralidoxime CompoundsSuccinylcholineParasympathetic Nervous SystemApolipoproteins EFenitrothionCarbarylNeuroprotective AgentsDouble-Blind MethodPeptide FragmentsPresenilin-2Rats, Sprague-DawleyReceptors, CholinergicAlkaloidsAgingButyrylthiocholineHippocampusExcitatory Amino Acid AntagonistsNeuronsAcetylthiocholineSeverity of Illness IndexIsoflurophateMagnetic Resonance ImagingReceptors, NicotinicTreatment OutcomeAge of Onset